Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001178913-18-002613)

Filing Details

Accession Number:
0001178913-18-002613
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-10-02 17:22:37
Reporting Period:
2018-10-01
Accepted Time:
2018-10-02 17:22:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1606645 Foamix Pharmaceuticals Ltd. FOMX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1374174 D Alvin Howard C/O Foamix Pharmaceuticals Ltd.
2 Holtzman Street
Rehovot L3 7670402		 Vp Regulatory No Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2018-10-01 234 $5.81 41,789 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. This sale is mandated by the Issuer's non-discretionary policy that requires the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.